3 Top Big Pharma Dividend Stocks You Can Buy Right Now
Big pharma stocks have long been favorites for dividend-seeking investors, and for good reason. Major pharmaceutical companies typically generate strong cash flow, which allows them to pay high dividend yields for decades.
The great cash flow that enables big pharma companies to fund those attractive dividends stems from a stable of drugs that make lots of money while they enjoy patent exclusivity. Even when the drugs lose patent exclusivity, they can continue contributing substantially to the companies' bottom lines. While big pharma companies must continually reinvest into research and development to find the next generation of successful products, many also look to return some of the money they make to shareholders in the form of dividends.
AbbVie (NYSE: ABBV), Novartis (NYSE: NVS), and Pfizer (NYSE: PFE) have balanced the reinvestment into new products with rewarding shareholders with solid dividends exceptionally well. Here's why these are three top big pharma dividend stocks you can buy right now.
Source: Fool.com
AbbVie Inc. Stock
The stock is an absolute favorite of our community with 22 Buy predictions and no Sell predictions.
As a result the target price of 175 € shows a positive potential of 20.76% compared to the current price of 144.92 € for AbbVie Inc..
